United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Healthcare Industry News Ardent Health Partners’ $192m IPO breaks ground—What this means for the future of U.S. healthcare Ardent Health Partners, Inc. (NYSE: ARDT), a prominent healthcare provider for midsize urban communities across the United States,… byPallavi MadhirajuJuly 21, 2024